Factors associated with gastrointestinal perforation in a cohort of patients with rheumatoid arthritis

To estimate the incidence and risk factors for gastrointestinal (GI) perforation among patients with rheumatoid arthritis (RA).

[1]  D. Johnson,et al.  Validation of ICD‐9‐CM codes to identify gastrointestinal perforation events in administrative claims data among hospitalized rheumatoid arthritis patients , 2011, Pharmacoepidemiology and drug safety.

[2]  E. Giovannucci,et al.  Use of aspirin or nonsteroidal anti-inflammatory drugs increases risk for diverticulitis and diverticular bleeding. , 2011, Gastroenterology.

[3]  J. Gisbert,et al.  The changing face of hospitalisation due to gastrointestinal bleeding and perforation , 2011, Alimentary pharmacology & therapeutics.

[4]  C. Spettell,et al.  The incidence of gastrointestinal perforations among rheumatoid arthritis patients. , 2011, Arthritis and rheumatism.

[5]  H. Petri,et al.  Data-driven identification of co-morbidities associated with rheumatoid arthritis in a large US health plan claims database , 2010, BMC musculoskeletal disorders.

[6]  R. Spiller,et al.  Concurrent drug use and the risk of perforated colonic diverticular disease: a population-based case–control study , 2010, Gut.

[7]  F. Chan,et al.  Celecoxib versus omeprazole and diclofenac in patients with osteoarthritis and rheumatoid arthritis (CONDOR): a randomised trial , 2010, The Lancet.

[8]  L. G. García Rodríguez,et al.  Variability among nonsteroidal antiinflammatory drugs in risk of upper gastrointestinal bleeding. , 2010, Arthritis and rheumatism.

[9]  F. Chan,et al.  A Novel Composite Endpoint to Evaluate the Gastrointestinal (GI) Effects of Nonsteroidal Antiinflammatory Drugs Through the Entire GI Tract , 2010, Journal of Rheumatology.

[10]  Á. Lanas,et al.  Time Trends and Impact of Upper and Lower Gastrointestinal Bleeding and Perforation in Clinical Practice , 2009, The American Journal of Gastroenterology.

[11]  R. Goetzel,et al.  Long-term medical costs and resource utilization in systemic lupus erythematosus and lupus nephritis: a five-year analysis of a large medicaid population. , 2009, Arthritis and rheumatism.

[12]  Á. Lanas,et al.  Mortality with upper gastrointestinal bleeding and perforation: effects of time and NSAID use , 2009, BMC gastroenterology.

[13]  C. Cannon,et al.  Assessment of upper gastrointestinal safety of etoricoxib and diclofenac in patients with osteoarthritis and rheumatoid arthritis in the Multinational Etoricoxib and Diclofenac Arthritis Long-term (MEDAL) programme: a randomised comparison , 2007, The Lancet.

[14]  M. Hochberg,et al.  Three-tiered-copayment drug coverage and use of nonsteroidal anti-inflammatory drugs. , 2004, Archives of internal medicine.

[15]  H. Goh,et al.  Non-steroidal anti-inflammatory drugs and perforated diverticular disease: a case-control study. , 2002, Annals of the Royal College of Surgeons of England.

[16]  R. Makuch,et al.  Gastrointestinal toxicity with celecoxib vs nonsteroidal anti-inflammatory drugs for osteoarthritis and rheumatoid arthritis: the CLASS study: A randomized controlled trial. Celecoxib Long-term Arthritis Safety Study. , 2000, JAMA.

[17]  G. Singh,et al.  NSAID induced gastrointestinal complications: the ARAMIS perspective--1997. Arthritis, Rheumatism, and Aging Medical Information System. , 1998, The Journal of rheumatology. Supplement.

[18]  J. Senior,et al.  Misoprostol Reduces Serious Gastrointestinal Complications in Patients with Rheumatoid Arthritis Receiving Nonsteroidal Anti-Inflammatory Drugs , 1995, Annals of Internal Medicine.

[19]  D. Furst,et al.  Low dose long-term corticosteroid therapy in rheumatoid arthritis: an analysis of serious adverse events. , 1994, The American journal of medicine.

[20]  K. Nair,et al.  Categorization of infliximab dose changes and healthcare utilization and expenditures for patients with rheumatoid arthritis in commercially insured and Medicare-eligible populations. , 2009, Current medical research and opinion.

[21]  G. Alarcón,et al.  Chapter 10 Gastrointestinal Manifestations of Rheumatoid Arthritis , 2008 .

[22]  H. Dobashi,et al.  [Gastrointestinal manifestations in rheumatoid arthritis]. , 2005, Nihon rinsho. Japanese journal of clinical medicine.